Diffuse Parenchymal Lung Disease
7 clinical trials · Condition
◉ Watch Diffuse Parenchymal Lung Disease
| Record | Firm | Date |
|---|---|---|
| Ultra-Low Dose Computed Tomography For Diagnosis And Follow-Up Of Patients With Diffuse Parenchymal Lung Disease (DPLD) (NCT04392726) | Sheba Medical Center | 2020-08-01 |
| Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD) (NCT02615938) | Matthias Griese | 2015-08-21 |
| The Clinical Value of Serum KL-6 Changes on Evaluating Disease Development in Different Diffuse Parenchymal Lung Disease (NCT03101397) | The First Affiliated Hospital of Guangzhou Medical University | 2013-02-01 |
| Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) (NCT01462006) | University of Virginia | 2011-10-01 |
| Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease (NCT01948518) | The Cleveland Clinic | 2009-06-01 |
| Race, Ethnicity, and Diffuse Parenchymal Lung Disease (NCT00453713) | Columbia University | 2006-07-01 |
Track Diffuse Parenchymal Lung Disease automatically
Every clearance here is in the API, with alerts when new ones post.